| Israele | Turchia | Austria | |
| Terapia protonica per il cancro alla prostata | - | da $30,000 | da $80,000 |
Bookimed non aggiunge costi extra ai prezzi di Terapia protonica per il cancro alla prostata. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica per la tua Terapia protonica per il cancro alla prostata al tuo arrivo.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali in Terapia protonica per il cancro alla prostata e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di Terapia protonica per il cancro alla prostata.
Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.
He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.
Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.
Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.
He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.
His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.
He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.
Professor Ofer Merimsky — oncologo di spicco, specializzato in tumori ossei, tessuti molli, mesotelioma, cancro ai polmoni e lesioni metastatiche al fegato e ai polmoni. È il capo del dipartimento di tumori dello scheletro e dei tessuti molli del Centro Medico Suraski (Ichilov, Tel Aviv) e guida l'Associazione degli Oncologi Clinici in Israele.
Competenze principali e vantaggi per i pazienti:
I pazienti apprezzano il professor Merimsky per la sua profonda conoscenza dell'oncologia, la capacità di scegliere schemi di trattamento individuali e l'attenzione scrupolosa, garantendo sicurezza e fiducia in tutte le fasi della terapia.